Division of Child and Adolescent Psychiatry, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.
Child Psychiatry Hum Dev. 2020 Aug;51(4):625-635. doi: 10.1007/s10578-020-00961-2.
The impact of externalizing comorbidity on treatment outcome was examined in 104 youth ages 7-16 (M = 11.09 years) with autism spectrum disorder and primary anxiety/obsessive compulsive disorder who completed modular cognitive behavioral therapy (CBT) for anxiety/OCD. Three comorbidity profiles were utilized for group comparisons: participants with oppositional defiant or conduct disorder with attention-deficit hyperactivity disorder (ODD; CD; ADHD; group EXT, n = 25); those without ODD/CD and only ADHD (group ADHD, n = 46); and those without externalizing comorbidity (NO-EXT, n = 33). Post-treatment outcomes were measured continuously (Pediatric Anxiety Rating Scale, Clinical Global Impression-Severity) and categorically (treatment response, remission). The ADHD group was four times more likely of being a treatment responder compared to NO-EXT (OR 4.05). Comorbidity group did not impact remission. After controlling for pre-treatment scores, there was a significantly greater reduction of the CGI-S for ADHD versus NO-EXT and EXT versus NO-EXT, but results did not significantly differ for the PARS. Results suggest that a modular CBT approach yields positive impact for treatment outcomes in youth with comorbid externalizing problems, particularly among those with comorbid ADHD.
本研究旨在探讨 104 名 7-16 岁(平均年龄 11.09 岁)自闭症谱系障碍合并原发性焦虑/强迫症青少年患者的共病情况对治疗效果的影响,这些患者接受了模块化认知行为疗法(CBT)治疗焦虑/强迫症。研究采用三种共病模式进行分组比较:伴有对立违抗性障碍或品行障碍合并注意缺陷多动障碍(ODD;CD;ADHD;EXT 组,n=25)、无 ODD/CD 且仅有 ADHD(ADHD 组,n=46)和无共病(NO-EXT 组,n=33)。治疗后采用连续(儿童焦虑量表,临床整体印象严重程度)和分类(治疗反应,缓解)两种方式评估疗效。结果显示,ADHD 组的治疗反应率是 NO-EXT 组的 4 倍(OR=4.05),而共病模式对缓解率无显著影响。调整基线评分后,ADHD 组的 CGI-S 评分显著低于 NO-EXT 组和 EXT 组,但 PARS 评分无显著差异。这些结果表明,模块化 CBT 对合并有外化问题的青少年治疗效果有积极影响,尤其是对合并有 ADHD 的患者。